Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer By Ogkologos - April 7, 2026 72 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POLAR study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast Cancer MOST POPULAR Satisfying Snacks November 13, 2020 Preparación para el fin de la emergencia de salud pública (PHE)... April 3, 2023 Some Children with Liver Cancer May Need Less Chemotherapy, Study Suggests May 9, 2019 ¿Pueden confundirse los síntomas del cáncer con la menopausia? November 1, 2022 Load more HOT NEWS Cancer in My Community: Obstacles to Caring for People With Cancer... Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation... Speaking a thousand words – how a cancer image collection is... Boosting Dendritic Cells Helps the Immune System Find Pancreatic Cancer
